Search the Newsreel

20,885 Shares in Akamai Technologies, Inc. $AKAM Acquired by Dockside LLC

Dockside LLC recently acquired 20,885 shares of Akamai Technologies, Inc. (NASDAQ:AKAM) valued at approximately $2.47 million during the second quarter. This acquisition is part of broader institutional investment in Akamai, with 94.28% of the stock owned by institutional investors and hedge funds. Akamai Technologies …

Akamai’s Q2 Earnings Call: Our Top 5 Analyst Questions

Akamai's second quarter results were met with a strong market response, following management's emphasis on the rapid expansion of its cloud infrastructure services and continued demand for security solutions. CEO F. Thomson Leighton highlighted that AI-driven workloads and large-scale enterprise commitments fueled growth, specifically …

Akari Therapeutics targets mid-2027 phase 1 trial for AKTX-101

Akari Therapeutics reported its Q2 2026 financial results, including raising $8.6 million in gross proceeds. The company announced plans to initiate a Phase 1 clinical trial for its lead antibody drug conjugate candidate, AKTX-101, by mid-2027. AKTX-101 utilizes a proprietary PH1 payload targeting RNA …

Akamai Technologies Facing Inflecting Cloud Services Opportunity, RBC Says

Akamai Technologies' (AKAM) unique platform is proving to be a rare opportunity in the compute space and has cemented about $2.8 billion in cloud infrastructure service deals year to date, RBC Capital Markets said in a note emailed Friday after meeting company executives Silver …

Akari Therapeutics reports Q2 results

* Akari Therapeutics press release [https://seekingalpha.com/filing/309948312] (AKTX [https://seekingalpha.com/symbol/AKTX]): Q2 net loss was $4.8 million, compared with $1.9 million for the second quarter of 2025. * Cash totaled $7.7 million as of June 30, 2026, compared with $5.2 million as of December 31, 2025. * …

Prakash Pipes Q1 Results: Net profit up 59% YoY to ₹16.4 crore

Prakash Steelage Q1 Results: Net profit falls 59% YoY to ₹16.35 lakh

Assenagon Asset Management S.A. Takes $2.47 Million Position in Akamai Technologies, Inc. $AKAM

Assenagon Asset Management S.A. recently acquired a new position in Akamai Technologies, Inc. by purchasing 20,931 shares worth approximately $2.47 million. This move is part of broader institutional investor activity, with various firms adjusting their stakes in AKAM. Despite mixed analyst sentiment, Akamai reported …

Akamai (AKAM) Is Up 5.7% After Mixed Q2 Results and AI Security Push - Has The Bull Case Changed?

The Technical Signals Behind (AKA) That Institutions Follow

A.k.a. Brands Holding Corp. (NYSE: AKA) is showing stable neutral readings in shorter horizons, potentially indicating an easing of a long-term weak bias. The AI models have generated three distinct trading strategies: a Position Trading Strategy, a Momentum Breakout Strategy, and a Risk Hedging …

Akari Therapeutics Q2 Results: Net loss widens to $4.8 million

Akari Therapeutics reported a net loss of $4.8 million for Q2 2026, widening from $1.9 million year-over-year, primarily due to increased R&D expenses as it advances its lead ADC candidate, AKTX-101, towards mid-2027 Phase 1 trials. The company strengthened its financial position by raising …

Akamai Technologies Takes Over #415 Spot From Leidos Holdings

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, Akamai Technologies Inc (Symbol: AKAM) has taken over the #415 spot from Leidos Holdings Inc (Symbol: LDOS), according to The Online Investor. Market capitalization is an important …

Akari Therapeutics (AKTX) posts larger loss and flags going concern risk

Akari Therapeutics reports Q2 2026 net loss $4.8M, raises ~$8.6M, advancing AKTX-101 toward mid-2027 Phase 1

Akari Therapeutics reported a net loss of $4.8 million for Q2 2026 and held $7.7 million in cash. The company raised approximately $8.6 million in gross proceeds through a private placement and warrant exercises. Akari is advancing its lead ADC candidate, AKTX-101, towards a …

Astaka Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2026

Akamai Technologies (NASDAQ:AKAM) Upgraded to "Neutral" at JPMorgan Chase & Co.

JPMorgan Chase & Co. upgraded Akamai Technologies (NASDAQ:AKAM) from an "underweight" to a "neutral" rating, setting a $158 price target. This upgrade follows Akamai reporting Q2 earnings slightly above expectations, with EPS of $1.59 and revenue of $1.10 billion. Analyst sentiment for AKAM remains …

Jagran Prakashan Share Price Target 2027, 2028 and 2030: Long Term Analyst Forecast

Prakash Steelage standalone net profit declines 57.89% in the June 2026 quarter

JPMorgan Upgrades Akamai Technologies to Neutral From Underweight, Adjusts PT to $158 From $132

JPMorgan has upgraded Akamai Technologies (AKAM) to Neutral from Underweight, raising its price target to $158 from $132. This upgrade reflects a more positive outlook for the company. The article also lists several other recent analyst adjustments for Akamai, displaying varying price target changes …

Akamai Technologies Inc. stock outperforms competitors on strong trading day

Akamai Technologies Inc. (AKAM) saw its stock rally 5.24% to $122.78 on Wednesday, outperforming the S&P 500 which rose 0.26%, and the Dow Jones Industrial Average which fell 0.04%. Despite this gain, the company's shares are still 25.79% below their 52-week high reached in …

Jagran Prakashan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Akamai Q2 Earnings Highlight AI Growth, Cloud Gains and Margin Risk

Akamai Technologies, Inc. AKAM reported second-quarter 2026 results that showed continued demand for its AI infrastructure and cybersecurity offerings. Revenue and adjusted earnings topped the Zacks Consensus Estimate, while higher operating expenses and infrastructure investments pressured profitability. Akamai Beats on Revenue and Adjusted EPS …

Akamai Stock Falls 22% in 3 Months as AI Growth Meets Execution Risks

Akamai Technologies, Inc. AKAM shares have declined 22.0% over three months, putting the company's shift toward AI infrastructure under greater investor scrutiny. The pullback comes as Cloud Infrastructure Services grows rapidly, while the legacy Delivery business remains under pressure. The key question is whether …

Is Akamai Stock a Buy as AI Growth Outpaces Delivery and Margin Risks

Akamai Technologies, Inc. AKAM presents a trade-off between accelerating AI infrastructure and Security opportunities and the financial costs of pursuing those markets. Cloud Infrastructure Services and Security are growing at double-digit rates, while Delivery remains under pressure and higher infrastructure spending is weighing on …

Akari Therapeutics (AKTX) sees Bank of Montreal group report 5.71% ownership

Bank of Montreal, Bank of Montreal Holding Inc., and BMO Nesbitt Burns Inc. have reported beneficial ownership of 8,000,000,000 Ordinary Shares of Akari Therapeutics (AKTX), representing 5.71% of the outstanding class as of June 30, 2026. The entities hold these shares as prime broker …

HSBC Just Downgraded Akamai Technologies Stock. Here’s Why.

HSBC downgraded Akamai Technologies (AKAM) from "Buy" to "Hold" and reduced its price target from $171 to $123 due to concerns about lower cloud infrastructure margins, slower earnings growth, and increased capital spending. Akamai's Q2 revenue of $1.1 billion was overshadowed by a decline …

Jagran Prakashan Q1FY27 net profit falls 8% as EBITDA rises 10%

Jagran Prakashan consolidated net profit declines 12.49% in the June 2026 quarter

Hindprakash Industries Q1 Results: Net profit rises 780% YoY

Krakatoa Resources Seeks ASX Quotation for 400 Million New Shares

Krakatoa Resources Expands Share Base with Major ASX Issuance

Kakatiya Cement AGM sees 54.6% voter turnout, passes all resolutions

Aakash Exploration Services standalone net profit declines 3.70% in the June 2026 quarter